Doptelet

Chemical Nameavatrombopag
Dosage FormTablet (oral; 20 mg)
Drug ClassReceptor agonists
SystemBlood
CompanyAkaRx
Approval Year2018

Indication

  • Doptelet is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
  • Doptelet is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.
Last updated on 2/4/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Doptelet (avatrombopag) Prescribing Information2019AkaRx